Immo Zadezensky

472 total citations
7 papers, 344 citations indexed

About

Immo Zadezensky is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Immo Zadezensky has authored 7 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in Immo Zadezensky's work include Pharmacogenetics and Drug Metabolism (3 papers), Cholesterol and Lipid Metabolism (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Immo Zadezensky is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Cholesterol and Lipid Metabolism (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Immo Zadezensky collaborates with scholars based in United States, France and Italy. Immo Zadezensky's co-authors include Veronika Butterweck, Susanne U. Mertens‐Talcott, Whocely Victor de Castro, Hartmut Derendorf, Chandrahas Sahajwalla, Sang Choe, Lokesh Jain, Sang M. Chung, Rajul K. Jain and Mona Khurana and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Planta Medica and Journal of Clinical Nursing.

In The Last Decade

Immo Zadezensky

7 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Immo Zadezensky United States 5 94 86 66 51 46 7 344
Supeecha Wittayalertpanya Thailand 11 68 0.7× 69 0.8× 40 0.6× 54 1.1× 20 0.4× 47 405
Lucy I. Darakjian United States 8 61 0.6× 90 1.0× 31 0.5× 91 1.8× 40 0.9× 11 406
Carmela Santuccio Italy 11 96 1.0× 124 1.4× 29 0.4× 63 1.2× 57 1.2× 21 706
Robert K. Drobitch United States 8 116 1.2× 95 1.1× 54 0.8× 148 2.9× 67 1.5× 12 478
Shirinsadat Badri Iran 15 42 0.4× 70 0.8× 45 0.7× 58 1.1× 42 0.9× 44 497
Bhaswat S. Chakraborty India 13 79 0.8× 77 0.9× 21 0.3× 76 1.5× 31 0.7× 42 429
Cui Yi-min China 12 61 0.6× 42 0.5× 28 0.4× 47 0.9× 46 1.0× 36 405
Leon Shargel United States 14 99 1.1× 135 1.6× 44 0.7× 89 1.7× 78 1.7× 40 609
Alice Wells United States 15 85 0.9× 124 1.4× 78 1.2× 166 3.3× 64 1.4× 43 568
Naina Mohamed Pakkir Maideen United Arab Emirates 12 54 0.6× 85 1.0× 31 0.5× 89 1.7× 18 0.4× 59 459

Countries citing papers authored by Immo Zadezensky

Since Specialization
Citations

This map shows the geographic impact of Immo Zadezensky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Immo Zadezensky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immo Zadezensky more than expected).

Fields of papers citing papers by Immo Zadezensky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Immo Zadezensky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Immo Zadezensky. The network helps show where Immo Zadezensky may publish in the future.

Co-authorship network of co-authors of Immo Zadezensky

This figure shows the co-authorship network connecting the top 25 collaborators of Immo Zadezensky. A scholar is included among the top collaborators of Immo Zadezensky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Immo Zadezensky. Immo Zadezensky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zadezensky, Immo, Jean‐Marc Guettier, Liang Li, et al.. (2018). Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism. Clinical Pharmacology & Therapeutics. 105(3). 710–718. 12 indexed citations
2.
Yu, Jingyu, Immo Zadezensky, Ke Hu, et al.. (2015). Utility of Exposure‐Response Analysis in Regulatory Decision on the Selection of Starting Dose of Pasireotide for Cushing Disease. The Journal of Clinical Pharmacology. 56(8). 1035–1038. 4 indexed citations
3.
Jain, Rajul K., Sang M. Chung, Lokesh Jain, et al.. (2011). Implications of Obesity for Drug Therapy: Limitations and Challenges. Clinical Pharmacology & Therapeutics. 90(1). 77–89. 157 indexed citations
4.
Schaffer, Susan D., Saunjoo L. Yoon, & Immo Zadezensky. (2009). A review of smoking cessation: potentially risky effects on prescribed medications. Journal of Clinical Nursing. 18(11). 1533–1540. 25 indexed citations
5.
Grundmann, Oliver, Stephen M. Phipps, Immo Zadezensky, & Veronika Butterweck. (2007). Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology. Planta Medica. 73(10). 1039–1046. 52 indexed citations
6.
Grundmann, Oliver, Stephen Paul Phipps, Immo Zadezensky, & Veronika Butterweck. (2007). Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology. Planta Medica. 73(10). 1139–1139. 4 indexed citations
7.
Mertens‐Talcott, Susanne U., Immo Zadezensky, Whocely Victor de Castro, Hartmut Derendorf, & Veronika Butterweck. (2006). Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided?. The Journal of Clinical Pharmacology. 46(12). 1390–1416. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026